Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer

Nicholas J. Vogelzang, Sridhar Mani, Richard L. Schilsky, Rafat H. Ansari, David Taber, Steven N. Rhinehart, Juan C. Garcia, Steven C. Meyer, Rosemarie Mick, Bruce E. Brockstein, Walter M. Stadler, Mark J. Ratain, Everett E. Vokes

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences